Quan Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
48
- Portfolio
-
17
- Exits
-
19
Quan Capital General Information
Company Description
Founded in 2017, Quan Capital is a venture capital firm based in Shanghai, China. The firm prefers to invest in the therapeutic biotech/pharma, enabling technologies/high-end specialty services, and companion diagnostic & precision medicine sectors.
Business Details
Website
quancapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 899 Halei Road, Building B, 4th floor
- Pudong New Area
- Shanghai
- China
Quan Capital Investments (48)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Windward Bio Group | 12-May-2026 | Early Stage VC | Drug Discovery | Generating Revenue/Not Profitable | ||
| Pinnacle Medicines | 26-Mar-2026 | Drug Discovery | Generating Revenue | |||
| Avenzo Therapeutics | 22-Aug-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Windward Bio Group | 10-Jan-2025 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Avenzo Therapeutics | 19-Nov-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Adcentrx Therapeutics | 05-Dec-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Crescendo Biologics | 24-Jul-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Alebund Pharmaceuticals | 12-Apr-2023 | Drug Discovery | Generating Revenue | |||
| Eluminex Biosciences | 14-Feb-2023 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Zenas BioPharma | 07-Nov-2022 | Early Stage VC | Drug Discovery | Generating Revenue |
Quan Capital Exits (19)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Windward Bio Group | 03-Nov-2026 | IPO | |
| Alebund Pharmaceuticals | 29-Jun-2026 | ||
| Zenas BioPharma | 26-Mar-2026 | ||
| Interius BioTherapeutics | 14-Oct-2025 | ||
| Zenas BioPharma | 13-Sep-2024 | ||
| Walking Fish Therapeutics | 04-May-2024 | ||
| Arcellx | 15-Jun-2022 | ||
| Arcellx | 04-Feb-2022 | ||
| Tempest Therapeutics | 28-Jun-2021 | Reverse Merger | |
| Design Therapeutics | 26-Mar-2021 | IPO |
Quan Capital Investments by Industry, Year, and Region
Quan Capital Co-Investors (68)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| LAV (Lilly Asia Fund) | 4 |
|
|
||
| OrbiMed |
|
|
|||
| Qiming Venture Partners |
|
|
|||
| RA Capital Management |
|
|
|||
| SR One |
|
|
Quan Capital FAQs
-
What is Quan Capital?
Founded in 2017, Quan Capital is a venture capital firm based in Shanghai, China.
-
When was Quan Capital founded?
Quan Capital was founded in 2017.
-
Where is Quan Capital headquartered?
Quan Capital is headquartered in Shanghai, China.
-
How many investments has Quan Capital made?
Quan Capital has made 48 investments.
-
What has Quan Capital invested in?
Quan Capital has made numerous investments in companies like Windward Bio Group, Pinnacle Medicines, and Avenzo Therapeutics within the Drug Discovery industry.
-
What has Quan Capital invested in recently?
Quan Capital's latest investment was on 12-May-2026 in Windward Bio Group, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process